Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Locally Advanced Breast Cancer
Interventions: DRUG: pyrotinib
Sponsor: RenJi Hospital